BeStock  
Stocks › Biotechnology › RPRX

Royalty Pharma RPRX

US equityMarket cap rank #641Biotechnology
$68.45 +$0.73 (+1.08%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $67.91 -0.79%
Open$68.17
Prev close$67.72
Day range$67.95 – $68.83
Volume3.53M
Market cap$30.48B
P/E (TTM)44.7
Dividend yield1.35%

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership87.6%-0.46 pts vs. prior quarter
Institutions holding902-4 vs. prior quarter
Insider trades (recent)25 buys / 25 sellsBalanced
Short interest2.94% of floatDays to cover 4.0 · as of 30 Oct 2026
Short-sale volume share14.7%5-day average of daily volume

Short-sale volume as % of daily volume

8%14%20%26%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$22.60M (8 inflow days, 12 outflow days).

Net flow by order size, last 20 sessions

−$33.4MSuper+$10.8MBig−$22.9MMid+$21.8MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 32.9% of shares outstanding.

Largest holders

  • Capital Research10.21%
  • Morgan Stanley Investment Management Inc.8.03%
  • BlackRock6.54%
  • Mario Giuliani4.80%
  • T. Rowe Price Group, Inc.3.30%
  • FMR3.20%
  • State Street Global Advisors2.91%
  • Swedbank Robur Fonder AB2.30%

By investor type

  • Mutual Fund74.51%
  • Individual/Insider6.11%
  • Hedge Fund4.73%
  • Public Company2.55%
  • Private Company2.03%
  • Government Pension Fund1.53%
  • Sovereign Wealth Fund1.28%
  • Family Office/Trust0.27%

Reported short interest has risen from 2.61% to 2.94% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
EFG Bank AG Private Company 2026/Q4 +3,935,402 0.9%
T. Rowe Price Group, Inc. Mutual Fund 2026/Q4 +3,518,480 3.3%
Invesco Ltd. Mutual Fund 2026/Q4 +2,987,686 1.4%
Victory Capital Management Inc. Mutual Fund 2026/Q4 +2,632,410 1.4%
UBS Asset Management Mutual Fund 2026/Q4 +2,561,101 1.3%
Deka Investment GmbH Mutual Fund 2026/Q4 +1,921,417 0.6%
Nordea Investment Management AB Mutual Fund 2026/Q4 +1,864,931 1.0%
Royal London Asset Management Ltd. Mutual Fund 2026/Q4 +1,654,110 1.3%
BlackRock Mutual Fund 2026/Q4 +1,284,419 6.5%
Managed Account Advisors LLC Mutual Fund 2026/Q4 +1,036,855 0.6%
Point72 Asset Management, L.P. Hedge Fund 2026/Q4 +1,016,707 0.3%
Franklin Resources Mutual Fund 2026/Q4 +975,048 0.6%
Alyeska Investment Group, L.P. Hedge Fund 2026/Q4 +938,028 0.2%
Vanguard Capital Management, LLC Mutual Fund 2026/Q4 +885,635 1.8%
Allianz Asset Management AG Mutual Fund 2026/Q4 +799,263 0.2%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
5 Nov 2026 Marshall Urist Head of Research & Investments Derivative Exercise and Retained +150,000 – 174,361
5 Nov 2026 Terrance Coyne Chief Financial Officer Other Acquisition +7,122 – 307,512
5 Nov 2026 Terrance Coyne Chief Financial Officer Derivative Exercise and Retained +250,000 – 307,512
3 Nov 2026 Christopher Hite Chairman of Partnering & Investments Other Acquisition +7,122 – 300,723
3 Nov 2026 Marshall Urist Head of Research & Investments Other Acquisition +5,341 – 174,361
3 Nov 2026 Pablo Legorreta Founder, Chairman of the Board & CEO Other Acquisition +42,209 – 4,954,404
4 Oct 2026 Marshall Urist Head of Research & Investments Automatic Disposition -4,126 $57.10 19,020
29 Sep 2026 Bonnie Bassler Independent Director Other Acquisition +642 $58.41 75,278
27 Sep 2026 Marshall Urist Head of Research & Investments Automatic Disposition -4,126 $57.88 23,146
21 Sep 2026 Christopher Hite Chairman of Partnering & Investments Automatic Disposition -100,000 $58.93 293,601
18 Aug 2026 Christopher Hite Chairman of Partnering & Investments Other Disposition -16,800 – 393,601
17 Aug 2026 Christopher Hite Chairman of Partnering & Investments Automatic Disposition -100,000 $59.97 393,601
12 Aug 2026 Terrance Coyne Chief Financial Officer Automatic Disposition -11,002 $59.14 50,390
6 Aug 2026 Marshall Urist Head of Research & Investments Other Derivative Disposition -3,000 – 244,412
6 Aug 2026 Terrance Coyne Chief Financial Officer Other Disposition -18,500 – –
6 Aug 2026 Pablo Legorreta Founder, Chairman of the Board & CEO Other Derivative Disposition -30,000 – 662,701
4 Aug 2026 Christopher Hite Chairman of Partnering & Investments Other Acquisition +11,002 – 510,401
4 Aug 2026 Marshall Urist Head of Research & Investments Other Acquisition +8,252 – 27,272
4 Aug 2026 Terrance Coyne Chief Financial Officer Other Acquisition +11,002 – 61,392
4 Aug 2026 Pablo Legorreta Founder, Chairman of the Board & CEO Other Acquisition +65,216 – 4,912,195

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 13,075,722 2.9% 4.0
15 Oct 2026 12,843,101 2.9% 4.3
30 Sep 2026 12,885,147 2.9% 4.4
15 Sep 2026 11,647,565 2.6% 3.3
31 Aug 2026 11,903,716 2.7% 5.1
14 Aug 2026 11,606,728 2.6% 3.8

Discussion

No comments yet — be the first to weigh in on RPRX.

Sign in to join the discussion.

Scroll to Top